Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect.
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effect.
复制标题
DOI：
10.1136/ebm1200
复制
发表时间：
2011-08-01
期刊：
影响因子：
--
通讯作者：
Mooney, Marc E
中科院分区：
文献类型：
--
作者：
Sofuoglu, Mehmet;Duffey, Dianne;Mooney, Marc E
Commentary on: CahillKSteadLFLancasterT. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2010;12:CD006103.
